{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:53:39Z","timestamp":1793408019863,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2024-04541"],"award-info":[{"award-number":["RGPIN-2024-04541"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbrc.2025.153050","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:57:51Z","timestamp":1764172671000},"page":"153050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["HIF-1\u03b1 silencing downregulates SLC37A2, SLC37A3, and G6PC3 gene expression and impacts glioblastoma stemness features in 3D neurospheres"],"prefix":"10.1016","volume":"794","author":[{"given":"Abdallah","family":"Fallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Zgheib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Zilinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-3689","authenticated-orcid":false,"given":"Bogdan Alexandru","family":"Danalache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-7183","authenticated-orcid":false,"given":"Borhane","family":"Annabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bbrc.2025.153050_bib1","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/cells13181574","article-title":"Metabolic reprogramming in Glioblastoma Multiforme: a review of pathways and therapeutic targets","volume":"13","author":"Cortes Ballen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbrc.2025.153050_bib2","article-title":"Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance","volume":"13","author":"D'Aprile","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2025.153050_bib4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bjc.6605551","article-title":"Hypoxia inducible factors in cancer stem cells","volume":"102","author":"Heddleston","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2025.153050_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1384249","article-title":"Hypoxia within the glioblastoma tumor microenvironment: a master saboteur of novel treatments","volume":"15","author":"Feldman","year":"2024","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.bbrc.2025.153050_bib6","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/cancers16172975","article-title":"Recent treatment strategies and molecular pathways in resistance mechanisms of antiangiogenic therapies in glioblastoma","volume":"16","author":"Rahman","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bbrc.2025.153050_bib7","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.3390\/cancers12113244","article-title":"Lactate in the tumor microenvironment: an essential molecule in cancer progression and treatment","volume":"12","author":"P\u00e9rez-Tom\u00e1s","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41420-025-02390-3","article-title":"Lipid metabolism: the potential therapeutic targets in glioblastoma","volume":"11","author":"Lu","year":"2025","journal-title":"Cell Death Discov."},{"issue":"9","key":"10.1016\/j.bbrc.2025.153050_bib9","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.bbrc.2025.153050_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/bios14110539","article-title":"Recapitulating glioma stem cell niches using 3D spheroid models for glioblastoma research","volume":"14","author":"Jo","year":"2024","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","article-title":"Spherical cancer models in tumor biology","volume":"17","author":"Weiswald","year":"2015","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrc.2025.153050_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/2041731420933407","article-title":"3D culture technologies of cancer stem cells: promising ex vivo tumor models","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Tissue Eng."},{"key":"10.1016\/j.bbrc.2025.153050_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbc.2025.100049","article-title":"Enzymes of glycolysis and the pentose phosphate pathway as targets of oxidants: role of redox reactions on the carbohydrate catabolism","volume":"11","author":"Fuentes-Lemus","year":"2025","journal-title":"Redox Biochem. Chem."},{"issue":"14","key":"10.1016\/j.bbrc.2025.153050_bib15","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1016\/j.febslet.2010.05.046","article-title":"Glucose is necessary for stabilization of hypoxia-inducible factor-1alpha under hypoxia: contribution of the pentose phosphate pathway to this stabilization","volume":"584","author":"Osada-Oka","year":"2010","journal-title":"FEBS Lett."},{"issue":"11","key":"10.1016\/j.bbrc.2025.153050_bib16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1158\/1541-7786.MCR-14-0106-T","article-title":"Glucose-6-phosphatase is a key metabolic regulator of glioblastoma invasion","volume":"12","author":"Abbadi","year":"2014","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbrc.2025.153050_bib17","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11064-020-03113-z","article-title":"Hypothesis: a novel neuroprotective role for glucose-6-phosphatase (G6PC3) in brain to maintain energy-dependent functions including cognitive processes","volume":"45","author":"Dienel","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrc.2025.153050_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1265698","article-title":"A molecular signature for the G6PC3\/SLC37A2\/SLC37A4 interactors in glioblastoma disease progression and in the acquisition of a brain cancer stem cell phenotype","volume":"14","author":"Torabidastgerdooei","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2025.153050_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fchem.2018.00122","article-title":"The physiopathological role of the exchangers belonging to the SLC37 family","volume":"6","author":"Cappello","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrc.2025.153050_bib20","series-title":"The Heterogeneity of Cancer Metabolism","article-title":"Glucose metabolism in cancer: the Warburg effect and beyond","volume":"vol 1311","author":"Bose","year":"2021"},{"key":"10.1016\/j.bbrc.2025.153050_bib21","article-title":"Exploring mechanisms of glucose uptake regulation and dilution resistance in growing cancer cells","author":"Tveit","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrc.2025.153050_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fonc.2012.00018","article-title":"Glycogen synthesis is induced in hypoxia by the hypoxia-inducible factor and promotes cancer cell survival","volume":"2","author":"Pelletier","year":"2012","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.153050_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013643","article-title":"Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide","volume":"5","author":"Danalache","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2025.153050_bib24","article-title":"Training deep learning models for cell image segmentation with sparse annotations","author":"Sugawara","year":"2023","journal-title":"bioRxiv preprint"},{"issue":"W1","key":"10.1016\/j.bbrc.2025.153050_bib25","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2025.153050_bib26","series-title":"The Analysis of Biological Data","author":"Whitlock","year":"2015"},{"issue":"9","key":"10.1016\/j.bbrc.2025.153050_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023157","article-title":"SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.bbrc.2025.153050_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.mam.2012.05.010","article-title":"The SLC37 family of phosphate-linked sugar phosphate antiporters","volume":"34","author":"Chou","year":"2013","journal-title":"Mol. Aspect. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib29","article-title":"Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity","volume":"3","author":"Ortmann","year":"2024","journal-title":"BMJ Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13046-023-02724-y","article-title":"Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance","volume":"42","author":"Kao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/cancers13010102","article-title":"Acriflavine, a potent inhibitor of HIF-1\u03b1, disturbs glucose metabolism and suppresses ATF4-protective pathways in melanoma under non-hypoxic conditions","volume":"13","author":"Mart\u00ed-D\u00edaz","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bbrc.2025.153050_bib32","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.3390\/ijms25042060","article-title":"Therapeutic targeting of hypoxia-inducible factors in cancer","volume":"25","author":"Musleh Ud Din","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbrc.2025.153050_bib33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1634\/stemcells.2008-0855","article-title":"Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells","volume":"27","author":"Lord-Dufour","year":"2009","journal-title":"Stem Cell."},{"key":"10.1016\/j.bbrc.2025.153050_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2867-6-7","article-title":"The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression","volume":"6","author":"Belkaid","year":"2006","journal-title":"Cancer Cell Int."},{"issue":"15","key":"10.1016\/j.bbrc.2025.153050_bib35","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1016\/j.febslet.2006.05.071","article-title":"Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin","volume":"580","author":"Belkaid","year":"2006","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40164-024-00519-1","article-title":"Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells","volume":"13","author":"Shi","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2025.153050_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1227884","article-title":"Hypoxia-induced cancer cell reprogramming: a review on how cancer stem cells arise","volume":"13","author":"Abd","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbrc.2025.153050_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12943-025-02281-2","article-title":"3D tumor cultures for drug resistance and screening development in clinical applications","volume":"24","author":"Peng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbrc.2025.153050_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12195-024-00798-y","article-title":"Three-dimensional tumor models to study cancer stemness-mediated drug resistance","volume":"17","author":"Lamichhane","year":"2024","journal-title":"Cell. Mol. Bioeng."},{"key":"10.1016\/j.bbrc.2025.153050_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor glycolysis as a target for cancer therapy: progress and prospects","volume":"12","author":"Ganapathy-Kanniappan","year":"2013","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2025.153050_bib41","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3390\/ijms26051879","article-title":"Glucose metabolism and tumor microenvironment: mechanistic insights and therapeutic implications","volume":"26","author":"Andryszkiewicz","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2025.153050_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1522392","article-title":"Targeting glycolysis: exploring a new frontier in glioblastoma therapy","volume":"15","author":"Yang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2025.153050_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/oons\/kvad008","article-title":"Glioblastoma modeling with 3D organoids: progress and challenges","volume":"2","author":"Wang","year":"2023","journal-title":"Oxf Open Neurosci."},{"issue":"71","key":"10.1016\/j.bbrc.2025.153050_bib44","first-page":"2349","article-title":"Orange: data mining toolbox in python","volume":"14","author":"Demsar","year":"2013","journal-title":"J. Mach. Learn. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25017668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25017668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:25:16Z","timestamp":1781270716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25017668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S0006291X25017668"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153050","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIF-1\u03b1 silencing downregulates SLC37A2, SLC37A3, and G6PC3 gene expression and impacts glioblastoma stemness features in 3D neurospheres","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.153050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153050"}}